Trial · NCT05014061
Adenosine's Effect on STunning Resolution in Acute Myocardial Infarction
NCT05014061, Phase 3, Withdrawn, Vastra Gotaland Region
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Adenosine's Effect on STunning Resolution in Acute Myocardial Infarction. Trials, record NCT05014061. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05014061
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Adenosine's Effect on STunning Resolution in Acute Myocardial Infarction
- NCT number
- NCT05014061
- Status
- Withdrawn
- Phases
- Phase 3
- Enrollment
- 0 participants, actual
- Lead sponsor
- Vastra Gotaland Region
- Conditions
- Myocardial Ischemia
- Interventions
- Adenosine
- First posted
- 2021-08-20
- Last updated
- 2024-05-17
Source ClinicalTrials.gov
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | The resolution of myocardial stunning at 48 hours (StunningRes48h). | 48 hours | The proportion of stunning that has resolved at 48 hours will be calculated according to the formula: StunningRes48h = (%AkinesiaBaseline - %Akinesia48h) / (%AkinesiaBaseline - %Akinesia30days) where %AkinesiaT is defined as the endocardial length of the akinetic myocardium measured in end-diastole divided by the total endocardial length measured in end-diastole in the 2- and 4-chamber view, at time T (T= 48h or 30 days) |
| Secondary | Infarct size | 6 months | Infarct size, assessed by cardiac magnetic resonance imaging |
| Secondary | Ejection fraction | Day 1, Day 2, Day 3, Day 7, Day 14, Day 30 and 6 months | Ejection fraction, assessed by echocardiography |
| Secondary | Sustained ventricular tachycardia or fibrillation | 72 hours | Any sustained ventricular tachycardia or fibrillation within 72 hours |
| Secondary | High-grade atrioventricular block or sinus arrest | 72 hours | Any high-grade atrioventricular block or sinus arrest within 72 hours |
| Secondary | Cardiac assist device | 72 hours | Implantation of cardiac assist device within 72 hours |
| Secondary | Stroke | 6 months | Stroke within 6 months |
| Secondary | Mortality | 6 months | All-cause mortality within 6 months |
| Secondary | Rehospitalization | 6 months | Heart failure rehospitalization within 6 months |
| Secondary | Worsening heart failure | ≥12 hours | Worsening in-hospital heart failure after PCI |
1 to 10 of 11Source ClinicalTrials.gov
See all 11 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT05014061
GET https://conductscience.org/api/trials/v1/NCT05014061/registered